Abstract:Objective: To investigate the relations between the release of cholecystokinin octopeptide (CCK 8) in spinal cord and the decrease of morphine induced analgesia under neuropathic pain condition. Methods: Sciatic nerve transection in rats was used as an animal model of neuropathic pain. The contents of CCK 8 immunoreactivity ( ir) in cerebral spinal fluid (CSF) were determined 3, 7, 10, and 14 days after surgery. Pain thresholds (tail flick latency) were also monitored simultaneously after s.c. injection of morphine (4 mg/kg) and a CCK B receptor antagonist, L 365,260 (0.5 mg/kg). Results: (1) One week after unilateral sciatic nerve transection, CSF concentration of CCK 8 ir showed a 125% increase. The effect of morphine induced analgesia was significantly decreased, which could be reversed by CCK B antagonist. (2) In 1.5 2 weeks after surgery, the level of spinal CCK 8 also either reduced or kept normal. No change to morphine analgesia could be observed, and CCK B antagonist had no further effect. (3) Rats with sham surgery showed decreased morphine analgesia (i.e., tolerance) on the 14 th day after the 4 th injection of morphine. The analgesic effect of morphine could be enhanced by CCK B receptor blocker. Conclusion: The diminished analgesic effect of morphine maybe due to an over release of CCK 8. The level of centrally released CCK 8 may play an important role in the variation of opioid analgesia after sciatic nerve transection.